Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 69097-971

5 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 69097-971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 10/12.5 mg (90 tablets)

Lisinopril And Hydrochlorothiazide Tablets  10/12.5 mg (90 tablets)
Packaging label for Lisinopril and Hydrochlorothiazide Tablets, USP, with a strength of 10 mg/12.5 mg. The label indicates a quantity of 100 tablets. It includes storage instructions, manufacturer details (InvaGen Pharmaceuticals, a subsidiary of Cipla USA Inc.), and safety warnings. The Cipla logo is featured prominently, along with a barcode and a QR code.*
FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/12.5 mg (90 tablets)

Lisinopril And Hydrochlorothiazide Tablets  20/12.5 mg (90 tablets)
Lisinopril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg oral tablets, packaged as 100 tablets. The label shows it is Rx only, manufactured for Cipla USA Inc. and by InvaGen Pharmaceuticals, with storage instructions and a barcode included.*
FDA Label Image

Lisinopril And Hydrochlorothiazide Tablets 20/25 mg (90 tablets)

Lisinopril And Hydrochlorothiazide Tablets  20/25 mg (90 tablets)
Label for Lisinopril and Hydrochlorothiazide Tablets, USP, 20 mg/25 mg strength, manufactured by Cipla USA Inc. The label displays the product name, strength, tablet count (100 tablets), storage instructions, and manufacturer information. It includes a barcode, QR code, and lot/expiration placeholders on the right side.*
FDA Label Image

Structural Formula 1 (Image 01)

Structural Formula 1 (Image 01)
Chemical structure of Lisinopril, an active ingredient in Lisinopril and Hydrochlorothiazide tablets. The structure illustrates the molecular bonds including rings, amino groups, carboxyl groups, and side chains characteristic of Lisinopril, depicted along with two molecules of water (2H2O).*
FDA Label Image

Structural Formula 2 (Image 02)

Structural Formula 2 (Image 02)
Chemical structure diagram of the active ingredient from Lisinopril and Hydrochlorothiazide tablets, showing the molecular arrangement with chlorine, sulfur, nitrogen, oxygen, and hydrogen atoms in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.